language_icon
EN
HI

Mahamaya Lifesciences Share price

MAHALIFE

173

1.00 (0.58%)
Last updated on 20 May, 2026 | 11:16 IST
Today's High

173.00

Today's Low

173.00

52 Week Low

111.00

52 Week High

205.05

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Mahamaya Lifesciences Chart

Mahamaya Lifesciences Share Key Metrics

Volume
1200.00
Market Cap
402.57 CR
LTQ@LTP
1200@173.00
ATP
173
Var Margin
53.5 %
Circuit Range
154.8-189.2
Delivery %
87.5 %
Value
2.08 L
ASM/GSM
No
Market Lot
1200

Summary

Mahamaya Lifesciences share price is ₹173 as of 21 May, 2026. The stock Mahamaya Lifesciences intraday movement has stayed between ₹173.00 and ₹173.00, while on a 52-week basis,Mahamaya Lifesciences price 52 week high is ₹205.05 & its 52 week low is ₹111.00.
In terms of trading activity, Mahamaya Lifesciences has recorded a volume of 1200 shares, The Mahamaya Lifesciences has a market cap of ₹23405000 CR. The stock’s Average Traded Price (ATP) stands at ₹173.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1200 @ ₹173.00.
Mahamaya Lifesciences operates within a circuit range of ₹154.80 – ₹189.20, with a Value of ₹2.08 L. The Delivery Percentage for the day is 87.5%. Additionally, Mahamaya Lifesciences currently falls under the No framework, and trades with a market lot size of 1200.

Mahamaya Lifesciences Fundamentals

View More
P/E Ratio

31.1

P/B Ratio

3.54

Div. Yield

0

Sector P/E

37.36

Sector P/B

2.21

Sec. Div. Yield

0.38

Mahamaya Lifesciences Resistance and Support

Pivot 172.32

Resistance

First Resistance

174.19

Second Resistance

176.37

Third Resistance

178.24

Support

First Support

170.14

Second Support

168.27

Third Support

166.09

Mahamaya Lifesciences Shareholding Pattern

View More
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

56.35%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

4.77%

Domestic Institutional Investors

2.52%

Retail

36.36%

Others

0%

Total Promoters
MAR '26
56.35%

Mahamaya Lifesciences Corporate Actions

DateAgenda
2025-12-02Half Yearly Results

Mahamaya Lifesciences News

Mahamaya Lifesciences Ltd - 544611 - Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Mahamaya Lifesciences board will hold a meeting on May 25, 2026, to consider and approve its audited standalone and consolidated financial results for the half year and full financial year ended March 31, 2026.
May 20 2026 18:05:00

Mahamaya Lifesciences Ltd - 544611 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Mahamaya Lifesciences has rescheduled the utilization of its unutilized IPO proceeds of Rs. 32.79 crore, extending the timeline to March 31, 2028. This delay, representing 53% of the IPO funds, is attributed to project execution timelines for the Technical Manufacturing Plant.
May 15 2026 13:05:00

Multibagger hunter Vijay Kedia buys 4.5% in SME Mahamaya Lifesciences; adds smallcap SPML Infra in Q4

Ace investor Vijay Kedia acquired a 4.53% stake in Mahamaya Lifesciences during Q4FY26, indicating his confidence in the SME company's growth potential and aligning with his investment strategy for niche growth stories.
Apr 21 2026 16:04:00
Read More

About Mahamaya Lifesciences

NSE : 0  
BSE : 544611  
ISIN : INE0U9D01019  

Our Company was originally incorporated as a private limited Company under the name of “Mahamaya Life Sciences Private Limited” under the provisions of the Companies Act 1956 and the Certificate of Incorporation was issued by the Assistant Registrar of Companies NCT Delhi & Haryana on May 07 2002. Further our Company name was changed from “Mahamaya Life Sciences Private Limited” to “Mahamaya Lifesciences Private Limited” and a fresh Certificate of Incorporation dated February 15 2016 was issued by the Registrar of Companies Delhi.Moreover a Special Resolution was passed at the Extra-Ordinary General Meeting of our Company held on 29th October 2024 for conversion of our Company into a Public Limited Company and the name of our Company was changed from “Mahamaya Lifesciences Private Limited” to “Mahamaya Lifesciences Limited”. A fresh certificate of incorporation consequent to change of name was issued by the Registrar of Companies Central Processing Centre on November 19 2024. The Corporate Identity Number of our Company is U24233DL2002PLC115261.MAJOR EVENTS:2002- Incorporation of the Company in the name and style of “Mahamaya Life Sciences Private Limited” under Companies Act 1956.2016- Company name was changed from “Mahamaya Life Sciences Private Limited” to “Mahamaya Lifesciences Private Limited”.2018- The Company received CTE from the Gujarat Pollution Control Board and then began construction of factory in Dahej Gujarat.2021- The factory plant was completed and after obtaining License to Manufacture Insecticides from Directorate of Agriculture Government of Gujarat formulations of insecticide was started in the factory.2024- Conversion of the Company from private limited to public limited.

Read More

Mahamaya Lifesciences Management

NamePosition
Krishnamurthy GanesanManaging Director
Prashant KrishnamurthyExecutive Director
View More

Mahamaya Lifesciences FAQs

The Buying Price of Mahamaya Lifesciences share is 173 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Mahamaya Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mahamaya Lifesciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Mahamaya Lifesciences shares is 31.1. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Mahamaya Lifesciences shares is 3.54. Useful to assess the stock's value relative to its book value.

To assess Mahamaya Lifesciences’s valuation compare Sector P/E, P/B which are 37.36 & 2.21 with sector averages, along with growth rates and financial metrics.

The Market Cap of Mahamaya Lifesciences is 402.57 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Mahamaya Lifesciences share price is 205.05 & 111.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Mahamaya Lifesciences belongs to the Chemicals sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost